Fiverr International Ltd
NYSE:FVRR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Fiverr International Ltd
NYSE:FVRR
|
IL |
|
N
|
Newland Pharmaceutical Co Ltd
SZSE:301277
|
CN |
|
Beiersdorf AG
XETRA:BEI
|
DE |
|
Bruno Inc
TSE:3140
|
JP |
Balance Sheet
Balance Sheet Decomposition
Fiverr International Ltd
Fiverr International Ltd
Balance Sheet
Fiverr International Ltd
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
58
|
56
|
39
|
358
|
205
|
221
|
270
|
278
|
165
|
|
| Cash |
30
|
0
|
15
|
90
|
134
|
134
|
86
|
145
|
40
|
|
| Cash Equivalents |
28
|
56
|
24
|
268
|
71
|
87
|
184
|
133
|
125
|
|
| Short-Term Investments |
0
|
0
|
89
|
129
|
118
|
241
|
148
|
289
|
118
|
|
| Total Receivables |
1
|
1
|
3
|
5
|
14
|
19
|
24
|
34
|
34
|
|
| Other Current Assets |
0
|
40
|
56
|
98
|
131
|
144
|
153
|
155
|
163
|
|
| Total Current Assets |
59
|
97
|
187
|
591
|
468
|
625
|
594
|
756
|
481
|
|
| PP&E Net |
5
|
5
|
5
|
22
|
18
|
15
|
11
|
9
|
7
|
|
| PP&E Gross |
5
|
5
|
0
|
22
|
18
|
15
|
11
|
9
|
7
|
|
| Accumulated Depreciation |
1
|
2
|
0
|
4
|
6
|
8
|
9
|
11
|
11
|
|
| Intangible Assets |
2
|
4
|
7
|
6
|
49
|
15
|
11
|
42
|
37
|
|
| Goodwill |
0
|
1
|
11
|
11
|
77
|
77
|
77
|
110
|
126
|
|
| Long-Term Investments |
0
|
0
|
22
|
228
|
318
|
190
|
328
|
122
|
0
|
|
| Other Long-Term Assets |
4
|
4
|
4
|
3
|
1
|
2
|
1
|
30
|
34
|
|
| Other Assets |
0
|
1
|
11
|
11
|
77
|
77
|
77
|
110
|
126
|
|
| Total Assets |
70
N/A
|
111
+59%
|
236
+113%
|
861
+264%
|
932
+8%
|
924
-1%
|
1 024
+11%
|
1 070
+5%
|
685
-36%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
3
|
3
|
4
|
4
|
9
|
9
|
5
|
6
|
9
|
|
| Accrued Liabilities |
7
|
10
|
0
|
44
|
47
|
43
|
47
|
57
|
59
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
1
|
1
|
2
|
0
|
0
|
458
|
0
|
|
| Other Current Liabilities |
32
|
41
|
78
|
98
|
131
|
146
|
153
|
165
|
181
|
|
| Total Current Liabilities |
43
|
54
|
82
|
146
|
189
|
197
|
205
|
685
|
249
|
|
| Long-Term Debt |
4
|
3
|
6
|
354
|
372
|
453
|
455
|
0
|
0
|
|
| Other Liabilities |
0
|
1
|
0
|
16
|
24
|
8
|
7
|
22
|
24
|
|
| Total Liabilities |
47
N/A
|
57
+22%
|
88
+53%
|
516
+489%
|
585
+13%
|
658
+13%
|
668
+1%
|
707
+6%
|
273
-61%
|
|
| Equity | ||||||||||
| Common Stock |
111
|
178
|
306
|
517
|
586
|
566
|
641
|
727
|
786
|
|
| Retained Earnings |
88
|
124
|
158
|
173
|
238
|
288
|
284
|
366
|
378
|
|
| Other Equity |
0
|
1
|
0
|
1
|
1
|
12
|
1
|
2
|
4
|
|
| Total Equity |
23
N/A
|
54
+134%
|
149
+176%
|
345
+132%
|
347
+0%
|
266
-23%
|
356
+34%
|
363
+2%
|
412
+14%
|
|
| Total Liabilities & Equity |
70
N/A
|
111
+59%
|
236
+113%
|
861
+264%
|
932
+8%
|
924
-1%
|
1 024
+11%
|
1 070
+5%
|
685
-36%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
31
|
31
|
31
|
36
|
37
|
38
|
39
|
36
|
36
|
|